Skip to main content
. 2022 Oct 25;17(1):77. doi: 10.5334/gh.1162

Table 1.

Baseline clinical characteristics.


BASELINE CLINICAL CHARACTERISTICS ALL (n =616) MACCE GROUP (n =39) MACCE-FREE GROUP (n =577) p-VALUE

Age (year) – mean ± SD 72.81 ± 9.71 70.62 ± 9.48 72.96 ± 9.72 0.145

Sex (Female) – n (%) 292 (47.4%) 23 (59.0%) 269 (46.6%) 0.135

BMI (kg/m2) – mean ± SD 24.5 ± 4.2 25.1 ± 4.0 24.4 ± 4.2 0.360

Hypertension – n (%) 576 (93.5%) 38 (97.6%) 535 (93.2%) 0.502

Cerebrovascular disease – n (%) 30 (4.9%) 3 (7.7%) 27 (4.7%) 0.428

Diabetes require insulin therapy – n (%) 7 (1.1%) 0 (0.0%) 7 (1.2%) 0.489

Current or ex-smoker – n (%) 68 (11.0%) 2 (5.1%) 66 (11.4%) 0.297

Dyslipidemia – n (%) 467 (75.8%) 29 (74.4%) 438 (75.9%) 0.827

CKD required hemodialysis – n (%) 74 (12.0%) 10 (25.6%) 64 (11.1%) 0.018

History of previous ACS – n (%) 118 (19.2%) 6 (15.4%) 112 (19.4%) 0.536

History of previous CABG – n (%) 49 (8.0%) 7 (17.9%) 42 (7.3%) 0.028

History of previous PCI – n (%) 252 (40.9%) 14 (35.9%) 238 (41.2%) 0.511

LVEF – mean ± SD 1 55.59 ± 17.41 50.88 ± 16.18 55.94 ± 17.47 0.161

Hemoglobin level (g/dL) – mean ± SD 2 11.72 ± 1.82 10.35 ± 2.25 11.82 ± 1.75 <0.001

Creatinine level (mg/dL) – mean ± SD 3 1.90 ± 2.05 2.76 ± 2.75 1.84 ± 1.97 0.048

Indication stable CAD – n (%) 412 (66.9%) 23 (59.0%) 389 (67.4%) 0.278

Indication NSTE-ACS – n (%) 187 (30.4%) 14 (35.9%) 173 (30.0%) 0.437

Indication STEMI – n (%) 16 (2.6%) 2 (5.1%) 14 (2.4%) 0.269

Total lesion per patient – mean ± SD 1.08 ± 0.27 1.07 ± 0.26 1.08 ± 0.27 0.763

** Bold indicated statistically significant.

1. 40% of LVEF data were missing 2. 18.3% of serum Hb were imputed. 3. 14.3% of serum Cr were imputed.

ACS – acute coronary syndrome; BMI – body mass index; CABG – coronary artery bypass graft; CKD – chronic kidney disease; LVEF – left ventricular ejection fraction; MACCE – major adverse cardiovascular and cerebrovascular events; NSTE-ACS- non-ST elevation acute coronary syndrome; PCI – percutaneous coronary intervention; SD – standard deviation; STEMI – ST-segment elevation myocardial infarction.